Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sotera Health ( (SHC) ) has shared an update.
On May 20, 2026, Sotera Health Company and Sotera Health Holdings, LLC amended their first lien credit agreement with JPMorgan Chase Bank and a group of refinancing term lenders, securing $1.42 billion in new repriced term loans. The amendment reduced the interest rate spread on the facility’s term loans by 0.25 percentage point and set the new loans’ margin at Adjusted Term SOFR plus 2.25% with a zero floor, or optional alternate base rates, aiming to lower ongoing borrowing costs.
The repriced term loans carry a 1% annual amortization rate, a maturity date of May 30, 2031, and a 1% soft call premium on certain repricing transactions completed within six months of the amendment’s effective date. This refinancing move is poised to strengthen Sotera Health’s capital structure by extending debt maturities and modestly reducing interest expense, which may enhance financial flexibility for operations and growth initiatives.
The most recent analyst rating on (SHC) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Sotera Health stock, see the SHC Stock Forecast page.
Spark’s Take on SHC Stock
According to Spark, TipRanks’ AI Analyst, SHC is a Neutral.
The score reflects improving operating performance and a supportive earnings update with reaffirmed guidance and reduced legal overhang, partially offset by a highly leveraged balance sheet and uneven free-cash-flow conversion. Technicals are mildly positive but not yet a strong long-term uptrend, while the high P/E and lack of dividend support weigh on valuation.
To see Spark’s full report on SHC stock, click here.
More about Sotera Health
Sotera Health Company operates in the healthcare and life sciences services industry, providing sterilization and lab testing solutions that support pharmaceutical, medical device and other regulated product manufacturers. Through its subsidiaries, including Sotera Health Holdings, LLC, the company focuses on mission-critical safety and compliance services for global healthcare markets.
Average Trading Volume: 3,612,881
Technical Sentiment Signal: Hold
Current Market Cap: $4.38B
For an in-depth examination of SHC stock, go to TipRanks’ Overview page.